Arnaud Lallouette: Honored to Use My Voice to Advocate For Solutions
Arnaud Lallouette, Executive Vice President Global Medical & Patient Affairs at Servier, shared a post on LinkedIn:
“The gap in childhood cancer outcomes between high-income countries (HICs) and low- and middle-income countries (LMICs) is devastating and unacceptable.
This disparity is fueled by systemic issues that go far beyond access to medicine. We will only see real change when we improve every aspect of the patient experience—before, during, and after treatment. This is something I am deeply passionate about, and it’s a mission I’m proud to share with Servier, through the Access Cancer Treatment (ACT) for Children initiative.
I recently had the opportunity to author an opinion piece on this issue for CancerWorld magazine. I’m honored to use my voice to advocate for solutions, which start with support from the pharmaceutical industry.
Thanks a lot to all our partners and Servier colleagues making this Act for Children initiative a reality. Huge thanks to Manette le Grange for your dedication, passion, enthusiasm and drive. Without you, this initiative would have been impossible.
To read the article, click the link.”
Yeva Margaryan,
We will only see real change when we improve every aspect of the patient experience—before, during, and after treatment.”
More posts featuring CancerWorld on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023